Financial reports
ARS
2023 FY
Annual report to shareholders
9 Apr 24
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Entry into a Material Definitive Agreement
13 Feb 24
8-K
Other Events
13 Feb 24
8-K
Other Events
16 Jan 24
8-K
Departure of Directors or Certain Officers
19 Dec 23
8-K
Other Events
15 Dec 23
8-K
Entry into a Material Definitive Agreement
13 Dec 23
8-K
Other Events
8 Dec 23
8-K
Other Events
4 Dec 23
8-K
Other Events
16 Nov 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
13 Feb 24
S-8
Registration of securities for employees
7 Aug 23
S-8
Registration of securities for employees
8 Aug 22
S-3ASR
Automatic shelf registration
29 Jul 21
424B5
Prospectus supplement for primary offering
15 Jan 21
424B5
Prospectus supplement for primary offering
11 Dec 20
S-8
Registration of securities for employees
27 Jul 20
424B5
Prospectus supplement for primary offering
1 Jul 20
424B5
Prospectus supplement for primary offering
29 Jun 20
D/A
$1M in equity, sold $1M, 1 investor
10 Apr 20
Proxies
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
PRE 14A
Preliminary proxy
27 Mar 24
DEFA14A
Additional proxy soliciting materials
18 May 23
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
DEFA14A
Additional proxy soliciting materials
25 Apr 22
DEF 14A
Definitive proxy
25 Apr 22
PRE 14A
Preliminary proxy
12 Apr 22
Other
CORRESP
Correspondence with SEC
23 Jun 22
UPLOAD
Letter from SEC
13 Jun 22
UPLOAD
Letter from SEC
30 Apr 19
CORRESP
Correspondence with SEC
29 Apr 19
UPLOAD
Letter from SEC
26 Apr 19
CORRESP
Correspondence with SEC
23 Apr 19
UPLOAD
Letter from SEC
19 Apr 19
CT ORDER
Confidential treatment order
30 Nov 18
CT ORDER
Confidential treatment order
21 Dec 17
EFFECT
Notice of effectiveness
4 Dec 17
Ownership
4
Samarth Kulkarni
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
SC 13G/A
Capital International Investors
10 Apr 24
4
JAMES R. KASINGER
22 Mar 24
4
Raju Prasad
22 Mar 24
4
Samarth Kulkarni
22 Mar 24
144
Notice of proposed sale of securities
22 Mar 24
4
Raju Prasad
18 Mar 24
4
Samarth Kulkarni
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24